Official EU label nameGlossary entry 23836
QUATERNIUM-15
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 8 of 13 indexed market datasets: 12 country records and 0 EU Annex records. Every result and evidence gap is listed below.
Markets checked
13
Markets with evidence
8
Evidence gaps
5
Resolved identifiers
4
A missing local match is not permission, approval or proof of safety. It means no strong identity match was resolved in that indexed dataset.
Resolved substance identity
CAS:4080-31-351229-78-8
EC:223-805-0426-020-3
Ingredient index records:
11 matched or reported names
QUATERNIUM-15Cis-1-(3-chloroallyl)-3,5,7- triaza-1-azoniaadamantane chloride (cis-CTAC)Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC), quaternium-15cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC; cis-methenamine 3-chloroallylochloride)cis/trans-1-(3-Chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis/trans-CTAC; methenamine 3-chloroallylochloride; quaternium-15)Cis-1-(3-chloroallyl)-3,5,7- triaza-1-azoniaadamantane chlorideCis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride季铵盐-15 — quaternium-15（CAS No. 51229-78-8）쿼터늄-15(메텐아민 3-클로로알릴클로라이드)cloreto de cis-1-(3-cloralil)-3,5,7-triaza-1-azoniaada mantano (cis-CTAC) (quaternium-15)Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC), quaternium-15 (CAS No. 51229-78-8)
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | No local match | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | Prohibited | 2Open record 1Open record 2 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Review every linked record and exact conditions. |
| Canada CA | No local match | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Prohibited | 2Open record 1Open record 2 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Prohibited | 2Open record 1Open record 2 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | Prohibited | 1Open record 1 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | Review every linked record and exact conditions. |
| Japan JP | No local match | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Restricted | 1Open record 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Review every linked record and exact conditions. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Prohibited | 1Open record 1 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | Review every linked record and exact conditions. |
| India IN | Prohibited | 1Open record 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Prohibited | 2Open record 1Open record 2 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
No market rows match this filter.
Matching market records and conditions
New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC; cis-methenamine 3-chloroallylochloride)Prohibited
Schedule 4, reference 1385, source row 1472 · effective-2026-01-01
cis/trans-1-(3-Chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis/trans-CTAC; methenamine 3-chloroallylochloride; quaternium-15)Prohibited
Schedule 4, reference 1386, source row 1473 · effective-2026-01-01
ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026China
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025South Korea
MFDS Notice 2026-19, effective 18 March 2026Brazil
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Cis-1-(3-chloroallyl)-3,5,7- triaza-1-azoniaadamantane chloride (cis-CTAC)Prohibited
SFDA prohibited list, page 139, row 1 · live-snapshot-2026-08-30
Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC), quaternium-15Prohibited
SFDA prohibited list, page 139, row 2 · live-snapshot-2026-08-30
Chemical identity and properties
CAS 4080-31-3PubChem CID 20011
Quaternium 15
- IUPAC name
- 1-(3-chloroprop-2-enyl)-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride
- Molecular formula
- C9H16Cl2N4
- Molecular weight
- 251.15 g/mol
- Exact mass
- 250.0752019 Da
- Topological polar surface area
- 9.7 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 4
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Quaternium-15CHEBI:59607Dowicil 100N-(3-Chloroallyl)hexaminium chlorideDowicide Q1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chlorideCinartc 200Dowco 184
16 more reported names
E40U03LEM0NSC-1729711-(3-chloroallyl)-hexaminium chlorideRefChem:9304403,5,7-Triaza-1-azoniaadamantane, 1-(3-chloroallyl)-, chloride1-(3-chloroprop-2-en-1-yl)-1,3,5,7-tetraazatricyclo(3.3.1.1^(3,7))decan-1-ium chloride1-(3-chloroprop-2-en-1-yl)-1,3,5,7-tetraazatricyclo(3.3.1.13,7)decan-1-ium chloride223-805-0CTACHexamethylenetetramine chloroallyl chloride1-(CIS-3-CHLOROALLYL)-3,5,7-TRIAZA-1-AZONIA-ADAMANTANE CHLORIDE1-?(3-?Chloroallyl)?-?1,?3,?5,?7-?tetraazaadamantan-?1-?ium ChlorideUKHVLWKBNNSRRR-UHFFFAOYSA-MEpitope ID:1318021-(3-chloroallyl)-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane;chloride1-(3-Chloroprop-2-en-1-yl)-1,3,5,7-tetraazatricyclo[3.3.1.1~3,7~]decan-1-ium chloride
External database identifiers
- EPA DTXSID:DTXSID5024760
- PubMed:20573164
- PubMed:15218738
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 51229-78-8PubChem CID 6435993
cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
- IUPAC name
- 1-[(Z)-3-chloroprop-2-enyl]-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride
- Molecular formula
- C9H16Cl2N4
- Molecular weight
- 251.15 g/mol
- Exact mass
- 250.0752019 Da
- Topological polar surface area
- 9.7 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 4
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Chloroallyl methenamine chlorideQuaternium-15 cis-formUNII-LIT014L4RHLIT014L4RHCOSEPT 200EC 426-020-3QUATERNIUM-15 CIS-FORM [II]QUATERNIUM-15 CIS-FORM [MI]
16 more reported names
1-(3-CHLOROALLYL)-3,5,7-TRIAZA-1-AZONIAADAMANTANE CHLORIDE, CIS-QUATERNIUM-15 CIS-FORM (II)3,5,7-TRIAZA-1-AZONIATRICYCLO(3.3.1.13,7)DECANE, 1-((2Z)-3-CHLORO-2-PROPEN-1-YL)-, CHLORIDE (1:1)RefChem:126386426-020-3Dowicil 2001-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium chloridecis-N-(3-Chloroallyl) hexaminium chlorideHexamethylenetetramine cis-chloroallyl chlorideC9H16Cl2N41-(cis-3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloridecis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantantane Chloride1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride, cis form3,5,7-Triaza-1-azoniatricyclo(3.3.1.13,7)decane, 1-((2Z)-3-chloro-2-propenyl)-, chloride3,5,7-Triaza-1-azoniatricyclo(3.3.1.13,7)decane, 1-(3-chloro-2-propenyl)-, chloride, (Z)-1-[(2Z)-3-CHLOROPROP-2-EN-1-YL]-1,3,5,7-TETRAAZATRICYCLO[3.3.1.1(3),?]DECAN-1-IUM CHLORIDE
External database identifiers
- ChEMBL:CHEMBL3181805
- EPA DTXSID:DTXSID0035748
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
These source-specific lookups can add hazard, toxicology, identity and assessment context. A link is a research route, not a claim that the source contains an exact record.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Research this identityFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Research this identityILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Research this identityJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Research this identityNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Research this identityOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Research this identityUS EPA CompTox CTX APIs
DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Research this identityContinue the compliance check
1. Confirm identity
Match the supplier specification, CAS/EC identifiers and composition to this official label name. Similar wording is not proof of chemical equivalence.
2. Review restrictions
Check every exact Annex record shown above, plus CMR, nanomaterial, SCCS and later-amendment requirements that may apply.
3. Verify the formula
Evaluate concentration, product type, purity, warnings, claims and each target market before making a compliance decision.
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision